83 related articles for article (PubMed ID: 8105374)
1. Expression of an mdr gene is associated with a new form of resistance to dexamethasone-induced apoptosis.
Bourgeois S; Gruol DJ; Newby RF; Rajah FM
Mol Endocrinol; 1993 Jul; 7(7):840-51. PubMed ID: 8105374
[TBL] [Abstract][Full Text] [Related]
2. Reversal of multidrug resistance by RU 486.
Gruol DJ; Zee MC; Trotter J; Bourgeois S
Cancer Res; 1994 Jun; 54(12):3088-91. PubMed ID: 7911394
[TBL] [Abstract][Full Text] [Related]
3. Membrane permeability as a determinant of dexamethasone resistance in murine thymoma cells.
Johnson DM; Newby RF; Bourgeois S
Cancer Res; 1984 Jun; 44(6):2435-40. PubMed ID: 6722785
[TBL] [Abstract][Full Text] [Related]
4. Modulation of multidrug resistance gene expression by dexamethasone in cultured hepatoma cells.
Zhao JY; Ikeguchi M; Eckersberg T; Kuo MT
Endocrinology; 1993 Aug; 133(2):521-8. PubMed ID: 8102093
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic and molecular characterization of tumors in nude mice derived from a multidrug-resistant human leukemia cell line.
Hill AB; Beck WT; Trent JM
Cancer Res; 1988 Jan; 48(2):393-8. PubMed ID: 2891436
[TBL] [Abstract][Full Text] [Related]
6. Non-P-glycoprotein mediated mechanism for multidrug resistance precedes P-glycoprotein expression during in vitro selection for doxorubicin resistance in a human lung cancer cell line.
Baas F; Jongsma AP; Broxterman HJ; Arceci RJ; Housman D; Scheffer GL; Riethorst A; van Groenigen M; Nieuwint AW; Joenje H
Cancer Res; 1990 Sep; 50(17):5392-8. PubMed ID: 1974823
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists.
Yang JM; Goldenberg S; Gottesman MM; Hait WN
Cancer Res; 1994 Feb; 54(3):730-7. PubMed ID: 7905786
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-fos in human and murine multidrug-resistant cells.
Bhushan A; Abramson R; Chiu JF; Tritton TR
Mol Pharmacol; 1992 Jul; 42(1):69-74. PubMed ID: 1353251
[TBL] [Abstract][Full Text] [Related]
9. Non-p-glycoprotein-mediated multidrug resistance in detransformed rat cells selected for resistance to methylglyoxal bis(guanylhydrazone).
Weber JM; Sircar S; Horvath J; Dion P
Cancer Res; 1989 Nov; 49(21):5779-83. PubMed ID: 2571411
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of P-glycoprotein inhibitors on NIH3T3 cells transfected with wild-type (G185) or mutant (V185) multidrug transporters.
Cardarelli CO; Aksentijevich I; Pastan I; Gottesman MM
Cancer Res; 1995 Mar; 55(5):1086-91. PubMed ID: 7866993
[TBL] [Abstract][Full Text] [Related]
11. Genes amplified and overexpressed in human multidrug-resistant cell lines.
Van der Bliek AM; Baas F; Van der Velde-Koerts T; Biedler JL; Meyers MB; Ozols RF; Hamilton TC; Joenje H; Borst P
Cancer Res; 1988 Nov; 48(21):5927-32. PubMed ID: 2901906
[TBL] [Abstract][Full Text] [Related]
12. Sequential emergence of distinct resistance phenotypes in murine erythroleukemia cells under adriamycin selection: decreased anthracycline uptake precedes increased P-glycoprotein expression.
Slapak CA; Daniel JC; Levy SB
Cancer Res; 1990 Dec; 50(24):7895-901. PubMed ID: 1979251
[TBL] [Abstract][Full Text] [Related]
13. Expression of recombinant human multidrug resistance P-glycoprotein in insect cells confers decreased accumulation of technetium-99m-sestamibi.
Rao VV; Chiu ML; Kronauge JF; Piwnica-Worms D
J Nucl Med; 1994 Mar; 35(3):510-5. PubMed ID: 7906729
[TBL] [Abstract][Full Text] [Related]
14. Glucorticoid resistance in murine lymphoma and thymoma lines.
Bourgeois S; Newby RF; Huet M
Cancer Res; 1978 Nov; 38(11 Pt 2):4279-84. PubMed ID: 698966
[TBL] [Abstract][Full Text] [Related]
15. Characterization of multidrug-resistant pituitary tumor cells.
Nelson EJ; Hinkle PM
Endocrinology; 1992 Jun; 130(6):3246-56. PubMed ID: 1350759
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of ras and myc expression associated with mdr-1 overexpression in adriamycin-resistant tumor cells.
Banerjee S; Ganapathi R; Ghosh L; Yu CL
Cell Mol Biol; 1992 Sep; 38(6):561-70. PubMed ID: 1363885
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of P-glycoprotein and efficacy of trifluoperazine in multidrug-resistant cells.
Ganapathi R; Kuo T; Teeter L; Grabowski D; Ford J
Mol Pharmacol; 1991 Jan; 39(1):1-8. PubMed ID: 1670962
[TBL] [Abstract][Full Text] [Related]
18. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
[TBL] [Abstract][Full Text] [Related]
19. bcl-2 gene transfer increases relative resistance of S49.1 and WEHI7.2 lymphoid cells to cell death and DNA fragmentation induced by glucocorticoids and multiple chemotherapeutic drugs.
Miyashita T; Reed JC
Cancer Res; 1992 Oct; 52(19):5407-11. PubMed ID: 1394146
[TBL] [Abstract][Full Text] [Related]
20. Molecular/cytogenetic alterations accompanying the development of multidrug resistance in the J774.2 murine cell line.
Slovak ML; Lothstein L; Horwitz SB; Trent JM
Leukemia; 1988 Jul; 2(7):453-8. PubMed ID: 2899184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
